Reuters -- Generex Biotechnology Corp Announces FDA approval of use of company’s flagship buccal insulin product, Generex oral-Lyn, under the FDA’s treatment investigational new drug (IND) program.
Reuters -- Generex Biotechnology Corp Announces FDA approval of use of company’s flagship buccal insulin product, Generex oral-Lyn, under the FDA’s treatment investigational new drug (IND) program.
